Figure 1. Tissue multiplexing places multiple small tissue sections or regions on the same spatial transcriptomics capture area.

Summary

Tissue multiplexing in spatial transcriptomics helps research teams use a fixed capture area more efficiently by placing multiple small tissue sections, tissue regions, treatment groups, or study specimens on the same slide or capture surface when the platform and sample type allow it. This approach can improve study design efficiency for small tissues, pilot studies, repeated conditions, multi-region comparisons, and cohort-style layouts.

However, multiplexing is not simply "putting more tissue on one slide." It requires planning around tissue preservation, embedding strategy, section placement, RNA quality, tissue morphology, region annotation, platform rules, spatial coordinates, and downstream data interpretation. This guide explains when tissue multiplexing is useful, how separate embedding and combined embedding strategies differ, what QC checks matter before and after sectioning, and how researchers should plan deliverables and analysis boundaries for research-use spatial transcriptomics projects.

Key Takeaways

• Tissue multiplexing can help reduce unused capture area when tissue sections are small.
• It is most useful for small tissues, paired study groups, multiple biological replicates, and cohort-style layouts.
• FFPE and fresh frozen tissues should not be mixed in the same workflow unless the platform and protocol explicitly support that design.
• Sample quality differences can still cause uneven data depth across multiplexed regions.
• ROI annotation, section spacing, tissue orientation, and platform geometry must be planned before sectioning.
• Multiplexing improves layout efficiency but does not replace biological replicate planning, sample QC, or careful data interpretation.

Why Multiplexing Matters

Spatial transcriptomics connects molecular readouts with tissue architecture. A tissue section is placed on a capture area, imaged, processed, and analyzed so that gene expression can be interpreted in spatial context.

The challenge is that tissue samples rarely match the capture area perfectly.

A small organ, biopsy-sized research specimen, microdissected region, thin anatomical structure, or experimental model tissue may occupy only part of the available surface. If only one small section is placed on the slide, part of the capture area may remain unused. In larger studies, unused area can become a practical design problem, especially when many samples, treatment groups, or biological replicates must be profiled.

Tissue multiplexing addresses this problem by arranging more than one tissue section or region on the same capture surface when technically feasible.

Fixed Capture Area Meets Variable Tissue Size

Spatial transcriptomics platforms have defined capture geometries. Tissue samples, however, vary by species, organ, disease model, developmental stage, preservation method, and dissection strategy.

A mouse tissue region, plant meristem, small tumor region, organoid section, tissue microarray core, or thin anatomical layer may not fill the capture region. A larger tissue may need to be trimmed to focus on a region of interest. In both cases, layout decisions affect how efficiently the capture area is used.

Multiplexing can help match biological sample size to the available platform geometry.

When One Section Leaves Unused Space

A single section may be enough when the tissue fills the capture area and contains the region of interest. But if the tissue is much smaller than the capture area, adding additional sections may be considered.

Common examples include:

• Small animal tissues.
• Narrow anatomical regions.
• Microdissected specimens.
• Organoids or spheroids.
• Small plant organs.
• Multiple small regions from the same tissue.
• FFPE tissue cores in TMA-style layouts.
• Pilot studies comparing several conditions.

The goal is not to crowd the slide. The goal is to create a layout that supports clear sample separation, tissue imaging, molecular capture, region annotation, and downstream comparison.

Why Layout Efficiency Affects Study Design

Layout efficiency matters because spatial transcriptomics studies must balance tissue biology, sample quality, platform constraints, replicate design, and analysis goals.

A multiplexed layout may allow a project to compare several small samples in a shared processing context. It may also help screen multiple candidate regions before selecting samples for deeper analysis. In cohort-style designs, multiplexing may support more efficient use of FFPE research specimens.

However, layout efficiency is only useful when interpretation remains clear. If samples are too close together, uneven in quality, poorly oriented, or difficult to annotate, multiplexing may create more problems than it solves.

What Tissue Multiplexing Means

Tissue multiplexing in spatial transcriptomics refers to the physical placement of multiple tissue sections, sample regions, or tissue cores on one spatial capture surface or slide workflow. It is a sample layout strategy, not a molecular barcoding strategy.

This distinction matters. In this article, "multiplexing" means multiple tissue areas are arranged spatially on the same slide or capture surface. Each region still needs clear metadata, region labeling, and analysis tracking.

Multi-Section Placement

Multi-section placement is the most direct form of tissue multiplexing. Several tissue sections are positioned on the same slide or capture area with enough spacing to preserve region boundaries.

This design may be used for:

• Multiple small tissues.
• Several regions from one specimen.
• Paired experimental conditions.
• Multiple biological replicates.
• Small control and treated samples.
• Pilot comparisons across tissue types.

The planning goal is to make each tissue region identifiable in imaging and computational analysis. Each region should be linked to sample metadata before data analysis begins.

TMA-Style Spatial Transcriptomics

TMA-style design is another optional multiplexing strategy. It is most relevant for FFPE research specimens, especially when many small cores are arranged in a controlled layout.

A tissue microarray-style layout can support cohort-oriented research questions or high-throughput screening of archived specimens. A 2024 MIST study described combining conventional tissue microarray concepts with spatial transcriptomics to increase slide throughput and support customizable layouts.

TMA-style designs require careful attention to core size, orientation, spacing, morphology, RNA quality, and metadata tracking. They are useful in some research contexts, but they are not required for all multiplexed spatial transcriptomics projects.

What Multiplexing Does Not Mean

Tissue multiplexing does not mean every sample can be placed on the same slide. It also does not remove the need for biological replicates.

It does not automatically solve batch effects, sample quality differences, or uneven capture. It does not guarantee that every tissue will produce comparable data.

Multiplexing should be treated as a layout and feasibility strategy. It works best when paired with pre-sectioning review, platform-specific rules, tissue-level QC, and region-level analysis planning.

Best-Fit Use Cases

Tissue multiplexing is most useful when the research question benefits from placing multiple small or comparable regions within a shared spatial transcriptomics workflow. It is less useful when tissues are large, variable, fragile, or difficult to annotate.

Small Tissues and Limited ROI Area

Small tissues are the most common reason to consider multiplexing. A small specimen may not use the full capture area, but it may still contain valuable spatial information.

Examples include:

• Small animal organs.
• Early developmental tissues.
• Plant meristems, embryos, root tips, or floral structures.
• Organoids and spheroids.
• Microdissected tissue regions.
• Small tumor regions in research specimens.
• Rare or limited tissue material.

In these cases, multiplexing can help researchers avoid leaving large areas unused. It can also support side-by-side profiling of related samples.

Paired Groups or Multiple Conditions

A multiplexed layout can be useful when the study compares related groups, such as untreated and treated specimens, genotype comparisons, developmental stages, or exposure conditions.

The benefit is that samples can be processed within a shared slide or capture workflow when the design is compatible. But this does not remove the need for proper metadata.

Each tissue region should have a unique sample ID, group label, preservation method, section information, and region annotation. Without this structure, downstream comparison becomes difficult.

Replicate and Cohort-Style Studies

Multiplexing may also support replicate or cohort-style research. For example, several FFPE cores or small tissue regions may be arranged in a defined pattern.

This can improve layout consistency, but it does not change the meaning of biological replication. If multiple sections come from the same specimen, they may support technical or regional assessment, but they should not be treated as independent biological specimens unless the study design supports that interpretation.

For cohort-style designs, metadata becomes especially important. Each region needs a clear link to the source specimen, tissue type, condition, section position, and analysis group.

Pilot Designs Before Larger Profiling

Multiplexing can be useful for pilot studies. A research team may want to compare candidate tissue regions before committing to a larger experiment.

A pilot layout may help evaluate:

• Tissue preservation quality.
• Section integrity.
• Spatial expression signal.
• Morphology and image alignment.
• Region annotation clarity.
• Whether target cell populations or tissue structures are detectable.

Pilot data should be used to refine the full study design rather than overinterpreted as a final biological result.

Two Practical Layout Strategies

Figure 2. Separate embedding and combined embedding support different tissue multiplexing workflows.

Two common approaches are used for multiplexed spatial transcriptomics layouts: separate embedding with section-by-section placement, and combined embedding with shared sectioning. Each strategy has advantages and risks.

Neither approach is universally better. The right choice depends on tissue type, preservation method, morphology, orientation needs, sectioning behavior, and downstream analysis goals.

Separate Embedding, Separate QC, Section-by-Section Placement

In this strategy, each tissue is embedded separately, assessed separately, sectioned separately, and placed onto the slide or capture surface in a planned arrangement.

This strategy is useful when samples differ in size, shape, orientation, fragility, or quality. It allows each block to undergo its own QC review before placement.

Separate embedding may be suitable for:

• Tissues with different shapes.
• Samples that need individual orientation.
• Specimens with variable morphology.
• Tissue blocks with different quality profiles.
• Projects where each sample must be reviewed before section placement.

The main challenge is handling complexity. More manual placement steps can increase the need for careful tracking, spacing, and documentation.

Combined Embedding, Shared QC, Section-First Placement

In combined embedding, multiple tissues are embedded within one block. The block is then sectioned as a unit, so the relative positions of the tissues are preserved during sectioning.

This strategy can be useful when tissues are similar in size, preservation, and sectioning behavior. It can also help maintain a consistent layout across serial sections.

Combined embedding may be suitable for:

• Similar tissue types.
• Similar preservation conditions.
• Planned multi-region layouts.
• Repeated sectioning of the same arrangement.
• Designs where shared orientation is practical.

The main risk is that tissues may not sit in the same plane. If one region is too high, too low, tilted, or poorly embedded, section quality may vary across the layout.

Choosing Between the Two Approaches

Choosing between separate and combined embedding should happen before sectioning. The decision should consider both wet-lab feasibility and bioinformatics interpretation.

A useful decision rule is simple: if samples require different orientation or quality review, separate embedding may be safer. If samples are similar and must remain in a fixed layout, combined embedding may be practical.

Sample Feasibility Checks

Tissue multiplexing should be evaluated before slide processing. A layout that looks efficient on paper may fail if the tissue is too fragile, too large, too close to other regions, poorly oriented, or incompatible with the platform workflow.

Preservation Method

Preservation method is a primary feasibility factor. FFPE, fresh frozen, and fixed frozen tissues have different handling requirements, sectioning behavior, and molecular profiles.

In most cases, FFPE and fresh frozen tissues should not be mixed within the same multiplexed workflow unless the specific platform and protocol explicitly support that design. They require different preparation logic, and combining them can complicate processing and interpretation.

A project plan should specify:

• Preservation type.
• Embedding medium.
• Fixation history when relevant.
• Tissue age or storage context.
• Prior staining or sectioning history.
• Whether the sample has been reviewed for RNA quality.

Tissue Size and ROI Geometry

Tissue size should be evaluated relative to the capture area and the required spacing between regions. A tissue may be small enough to multiplex, but the actual region of interest may still require careful orientation.

Before sectioning, researchers should estimate:

• Tissue dimensions.
• ROI location.
• Required spacing between sections.
• Expected section shape.
• Whether tissue trimming is needed.
• Whether H&E review can guide ROI selection.
• Whether the planned layout leaves enough separation for image and data annotation.

A crowded layout can make analysis difficult. It may also increase the risk that tissue edges, folds, or adjacent regions interfere with segmentation or region labeling.

RNA Quality and Section Integrity

RNA quality affects spatial transcriptomics performance, especially for archived, degraded, or difficult tissues. The relevant QC metric depends on preservation method and platform.

Rather than using a universal threshold, feasibility review should focus on metric types such as:

• RNA quality assessment where applicable.
• Section integrity.
• Tissue morphology.
• Staining quality.
• Tissue adherence.
• Damage, necrosis, folding, tearing, or detachment.
• Consistency across samples.

A multiplexed design should not combine high-quality and visibly poor-quality tissues without a clear reason. Uneven sample quality can produce uneven data profiles across the slide.

Orientation, Spacing, and Plane Consistency

Orientation determines whether the desired anatomy is captured. This is especially important for layered tissues, vascular structures, small plant organs, embryos, and microdissected regions.

Spacing determines whether each tissue can be separately annotated. If sections are too close, image segmentation and region labeling may become ambiguous.

Plane consistency matters when several tissues are embedded together. If tissues are not aligned at the same cutting plane, some may section cleanly while others appear incomplete or distorted.

These layout issues should be addressed before sectioning, not after data generation.

Platform and Slide Considerations

Tissue multiplexing is platform-dependent. The same physical layout may be feasible on one workflow and unsuitable on another. For this reason, the platform rules should be checked early.

This article stays platform-neutral because multiplexing principles apply across different spatial transcriptomics workflows. Still, each workflow has its own requirements for slide type, capture surface, section placement, staining, imaging, permeabilization, probe chemistry, and data processing.

Capture Area and Tissue Placement

The capture area defines where tissue can produce spatial molecular data. Tissue outside the active region may still appear in an image but may not contribute usable molecular information.

Before sectioning, the layout should be planned against the actual capture geometry. Researchers should not assume that the full glass slide is active.

A layout sketch can help define:

• Where each tissue will sit.
• Which region belongs to which sample.
• How much spacing is needed.
• Which regions should be excluded.
• Whether the section fits within the active capture area.
• Whether the final orientation supports the biological question.

Standard Slides vs Direct Capture Surfaces

Some workflows allow tissue preparation on a standard slide followed by a transfer or assisted capture process. Other workflows require direct placement on a specialized capture surface.

This difference affects how multiplexing is performed. Direct-to-capture placement may require more precise section positioning because the tissue must be placed correctly the first time. Standard slide workflows may allow different handling steps but still require careful image registration and tissue selection.

The practical message is that slide handling should be decided with the platform in mind. The same sample layout plan may need to be adjusted depending on the workflow.

Why Platform Rules Must Be Confirmed Early

Platform rules affect preservation compatibility, section thickness, staining, imaging, capture area, and downstream analysis. They may also affect whether TMA-style layouts, serial sections, or multi-region arrangements are practical.

For broader method selection before tissue multiplexing is finalized, researchers can review Spatial Transcriptomics Platforms: Sequencing vs Imaging and How to Choose.

QC After Multiplexing

Figure 3. Multiplexed tissue layouts require both tissue-level and data-level QC before interpretation.

Multiplexing does not automatically reduce data quality, but it introduces additional QC responsibilities. Each tissue region must be evaluated individually and as part of the whole layout.

QC should happen at two levels: tissue-level QC and data-level QC.

Tissue-Level QC

Tissue-level QC checks whether the physical section and image support analysis.

Important checks include:

• Tissue morphology.
• Section integrity.
• Tissue adherence.
• Folding, tearing, cracking, or detachment.
• Staining quality.
• Presence of target ROI.
• Region separation.
• Orientation accuracy.
• Image alignment.
• Whether each sample can be clearly labeled.

These checks are essential because spatial transcriptomics is not just molecular profiling. The image, tissue structure, and region boundaries are part of the data interpretation.

Data-Level QC

Data-level QC evaluates whether each region has sufficient and comparable molecular information for the intended analysis.

Useful metric types include:

• Molecular count or read-depth distribution.
• Detected gene profile.
• Mapping or assignment metrics.
• Fraction of usable spots, bins, or cells.
• Region-level expression coverage.
• Background or ambient signal assessment when available.
• Spatial coordinate integrity.
• Cluster or region consistency.
• Replicate-level similarity where applicable.

The goal is not to force every region to look identical. Different tissues may naturally have different molecular profiles. The goal is to identify whether differences reflect biology, sample quality, technical variation, or layout effects.

Region-Level and Sample-Level Variation

In a multiplexed design, each tissue region should be evaluated as its own analytical unit. Data summaries should not only be reported for the whole slide.

Region-level reporting can identify whether one sample has lower signal, weaker morphology, poor alignment, or unusually sparse expression. It can also help prevent one poor region from distorting conclusions about the whole experiment.

If the project includes multiple groups, the analysis should separate biological variation from layout-related variation. Metadata should include sample identity, group, region label, slide position, preservation method, embedding strategy, and any relevant processing notes.

Bioinformatics and Region Annotation

A multiplexed slide does not automatically tell the analysis software which tissue is which. Clear region annotation is essential.

The bioinformatics plan should define how each tissue region will be separated, labeled, compared, and reported.

Sample Masks and ROI Labels

A sample mask defines which spatial coordinates belong to which tissue region. ROI labels define biologically meaningful areas within or across tissues.

For multiplexed layouts, sample masks should be reviewed carefully. If two tissue sections are close together, if a tissue is folded, or if a region has fragmented morphology, automated segmentation may need manual review.

Useful annotation layers include:

• Tissue region masks.
• Sample IDs.
• ROI labels.
• Exclusion zones.
• Tissue boundaries.
• Histology-guided annotations.
• Spatial coordinate mapping.
• Section or block identifiers.

These annotations should be preserved in deliverables so the analysis can be audited later.

Metadata for Each Tissue Region

Each tissue region should have a complete metadata entry. At minimum, this should include sample ID, tissue type, preservation method, group label, replicate status, layout position, and any sectioning notes.

For cohort-style layouts, metadata should be even more structured. A TMA-style design can include many cores, and each core must remain traceable to the correct specimen and study group.

Metadata errors are difficult to fix after analysis. A mislabeled region can lead to incorrect comparisons even if the molecular data are technically sound.

Comparing Regions Without Overcalling Batch Effects

Multiplexing may reduce some processing differences by placing samples in a shared workflow, but it does not eliminate all technical variation. Position on a slide, tissue quality, local processing effects, and sample biology can still influence the data.

Good analysis practice includes:

• Region-level QC.
• Sample-level summaries.
• Metadata-aware comparison.
• Clear exclusion criteria.
• Replicate-aware interpretation.
• Sensitivity checks when results depend on one region.
• Cautious interpretation when sample quality differs.

For downstream computational planning, spatial transcriptomics data analysis can include sample masks, ROI annotation, region-level comparison, and QC summaries when appropriate for the project.

When Multiplexing Is Not Recommended

Tissue multiplexing is not suitable for every spatial transcriptomics project. In some cases, running separate slides or capture areas may produce cleaner results and easier interpretation.

Large Quality Differences Between Samples

Multiplexing is risky when samples differ strongly in preservation quality, RNA integrity, morphology, or sectioning behavior. A slide containing one strong sample and several weak samples may generate uneven data that are hard to interpret.

This does not always mean the design is impossible. It does mean the weak samples should be reviewed before they are included in a multiplexed layout.

Risk signs include:

• Severe tissue degradation.
• Poor morphology.
• Extensive necrosis or damage.
• Weak section adherence.
• Fragmentation.
• Poor staining.
• Large differences in RNA quality metrics.
• Inconsistent tissue thickness or sectioning behavior.

Incompatible Preservation or Sectioning Needs

Samples with different preservation methods or processing needs should not be combined unless the workflow supports that combination. FFPE and fresh frozen tissue usually require different handling logic.

Other incompatibilities may include:

• Different section thickness requirements.
• Different staining needs.
• Different tissue hardness or fragility.
• Strongly different embedding behavior.
• Different decrosslinking or fixation requirements.
• Incompatible downstream assay chemistry.

Combining incompatible samples can create uneven processing and confusing interpretation.

Crowded Layouts That Complicate Annotation

A layout that maximizes the number of tissues may not maximize usable data. If tissues are too close, overlapping, folded, or hard to distinguish, region annotation becomes unreliable.

Crowded layouts can increase the risk of:

• Ambiguous tissue boundaries.
• Difficult sample masking.
• Misassigned spatial coordinates.
• Image registration problems.
• Region exclusion after data generation.
• Complicated downstream comparisons.

A conservative layout with fewer, cleaner regions is often more useful than an overcrowded layout.

Project Planning Checklist

A multiplexed spatial transcriptomics study should start with a layout plan, not only a sample list. The plan should connect biological questions, tissue geometry, platform constraints, and downstream analysis.

Information to Prepare

Before a feasibility discussion, prepare:

• Number of samples.
• Tissue type and species.
• Preservation method.
• Approximate tissue size.
• Desired ROI.
• H&E or morphology reference if available.
• Sample group labels.
• Biological replicate structure.
• Whether samples are independent or serial sections.
• Preferred platform or open platform selection.
• Embedding strategy if already decided.
• Sectioning constraints.
• Region annotation needs.
• Downstream analysis goals.
• Required deliverables.

This information helps determine whether multiplexing is technically feasible and biologically meaningful.

Questions to Ask Before Sectioning

Before cutting sections, ask:

• Does each tissue fit within the active capture area?
• Is there enough spacing between tissue regions?
• Are the tissues compatible in preservation and sectioning behavior?
• Can each region be clearly labeled in the image?
• Are biological replicates properly defined?
• Are sample groups balanced across layouts when needed?
• Is TMA-style design helpful or unnecessary?
• Will data analysis require region masks or manual annotation?
• What QC metrics will be reviewed per tissue region?
• What would cause a region to be excluded from analysis?

These questions reduce the risk of generating data that are difficult to interpret.

Research-Use Scope

This content and the described workflows are intended for research use only. They are not intended for clinical diagnosis, treatment decisions, disease monitoring, therapeutic decision-making, or individual health assessment.

In research projects, tissue multiplexing can support sample layout planning, pilot screening, spatial biology studies, tissue architecture research, and downstream bioinformatics. It should be presented as a study design strategy, not as a regulated testing workflow.

To evaluate whether tissue multiplexing is suitable for a spatial transcriptomics project, CD Genomics can review tissue size, preservation method, ROI layout, sample groups, platform preference, and downstream analysis goals for a research-use-only feasibility discussion. Related study designs may also be supported through spatial transcriptomics services.

FAQ

What is tissue multiplexing in spatial transcriptomics?

Tissue multiplexing in spatial transcriptomics is a layout strategy where multiple tissue sections, tissue regions, or small research specimens are placed on the same slide or capture surface when technically feasible. The purpose is to use the active capture area more efficiently while preserving spatial context for each sample. It requires planning around tissue spacing, preservation method, orientation, ROI annotation, platform rules, and downstream data analysis.

Can FFPE and fresh frozen tissues be multiplexed together?

In most cases, FFPE and fresh frozen tissues should not be multiplexed together in the same workflow unless the platform and protocol explicitly support that combination. These preservation types usually require different preparation, sectioning, staining, and processing conditions. Mixing them can complicate tissue handling and data interpretation. A feasibility review should confirm preservation compatibility before sectioning.

How many tissue sections can be placed on one spatial transcriptomics slide?

There is no universal number. The possible number depends on tissue size, capture area, platform geometry, section spacing, ROI needs, image registration, tissue morphology, and analysis goals. A smaller tissue does not automatically mean more sections should be added. The layout must still allow clean tissue boundaries, reliable sample masks, and interpretable region-level data.

Does tissue multiplexing reduce spatial transcriptomics data quality?

Tissue multiplexing does not inherently reduce data quality, but it can increase the need for careful QC. Data quality is influenced by tissue preservation, RNA quality, section integrity, morphology, capture efficiency, and region-specific processing. Multiplexed layouts should be evaluated per tissue region because one low-quality region can show weaker signal even if other regions perform well.

What QC metrics should be checked after tissue multiplexing?

Useful QC metric types include tissue morphology, section integrity, staining quality, image alignment, tissue boundary clarity, molecular count or read-depth distribution, detected gene profile, mapping or assignment metrics, spatial coordinate integrity, and region-level variation. The goal is to determine whether each tissue region supports the intended analysis and whether differences between regions are biological or technical.

How are different tissue regions separated during spatial transcriptomics data analysis?

Different tissue regions are separated using sample masks, ROI labels, spatial coordinates, histology-guided annotation, and metadata tables. Each region should be linked to a sample ID, group label, preservation method, replicate status, and layout position. In crowded or fragmented layouts, manual review may be needed to ensure that region boundaries and sample labels are correct.

Is tissue multiplexing better than running separate slides?

Tissue multiplexing is better only when it supports the study design without compromising interpretation. It can improve capture area use for small samples and support efficient side-by-side layouts, but separate slides may be better for large tissues, incompatible preservation types, complex anatomy, or samples with very different quality profiles. The best choice depends on sample feasibility and research goals.

References

1. Microarray Integrated Spatial Transcriptomics (MIST) for high-throughput spatial transcriptomics. NPJ Systems Biology and Applications, 2024.
2. Visium HD FFPE Tissue Preparation Handbook. 10x Genomics Support.
3. Visium HD Spatial Applications Imaging Guidelines. 10x Genomics Support.
4. Systematic benchmarking of high-throughput subcellular spatial transcriptomics platforms. Nature Communications, 2025.
5. Spatial analysis by current multiplexed imaging technologies in cancer research. British Journal of Cancer, 2024.
6. Visium CytAssist Documentation. 10x Genomics Support.